Response Biomedical launches Ramp technology in 3M’s flu test
The test is branded by 3M as the 3M Rapid Detection Flu A+B Test. This rapid flu test provides hospital and physician office laboratories reliable and objective electronic
Tolerance Bio has signed an agreement securing an exclusive licence from Tanabe Pharma for TLB-33, a clinical-stage anti-IL-33 monoclonal antibody, in a deal that includes potential development and sales milestone payments of up to around $560m.
Elixir has conducted five first-in-human clinical studies evaluating the therapeutic effectiveness of the company’s Novolimus-eluting and Myolimus-eluting stent systems. Novolimus and Myolimus are macrocyclic lactones in the same